The Synthetic Biology Consortium meets annually to facilitate important discussions focused on synthetic biology and cultivate a culture of synthetic biology research at the NIH. The 2022 Synthetic Biology Consortium Meeting continued to facilitate networking and collaboration among synthetic biology investigators and NIH program directors. This year’s meeting focused on control theory approaches to create robust synthetic biology technologies that are safe and predictable, especially in the context of human health.

Welcoming Remarks

• Dr. Dinah Singer, NCI Deputy Director for Scientific Strategy and Development

Invited Talks

• Dr. Domitilla Del Vecchio, MIT
• Dr. Josh Leonard, Northwestern
• Dr. Marcella Gomez, UCSC

Virtual Breakout Sessions

Prior to this meeting, the Synthetic Biology Consortium hosted three breakout sessions focused on specific topics within control theory prior to the main meeting. Please visit the Synthetic Biology Consortium Meeting website to review descriptions of the breakout topics and learn more about the agenda, speakers, and session topics for this meeting.

November 18, 2022 | 6:00 - 8:00 PM EST

Control Theory Toolkits and Modeling

Josh Leonard (Northwestern) and Jermont Chen (NIBIB)

November 30, 2022 | 1:00 - 4:00 PM EST

Engineering Biology Capabilities and Bottlenecks

Domitilla Del Vecchio (MIT) and Tuba Fehr (NICHD)

December 6, 2022 | 12:00 - 2:30 PM EST

Scaling up Biocontrol Methods to Complex Biological Systems

Marcella Gomez (UCSC) and Eric Johnson (NCI)